Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


24.07.2017

1 Ann Surg
1 BMC Surg
1 Eur J Cancer
1 Gastrointest Endosc
1 Gut
2 Int J Cancer
3 Int J Oncol
1 Oncol Rep
1 PLoS One
1 Surgery


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. ALVINO DML, Chang DC, Adler JT, Noorbakhsh A, et al
    How Far Are Patients Willing to Travel for Gastrectomy?
    Ann Surg. 2017;265:1172-1177.
    PubMed     Text format     Abstract available


    BMC Surg

  2. ANUP S, Lu J, Zheng CH, Li P, et al
    Prognostic significance of perigastric tumor deposits in patients with primary gastric cancer.
    BMC Surg. 2017;17:84.
    PubMed     Text format     Abstract available


    Eur J Cancer

  3. PARK SR, Kim MJ, Nam BH, Kim CG, et al
    A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer.
    Eur J Cancer. 2017;83:32-42.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  4. YANG HJ, Kim SG, Lim JH, Choi JM, et al
    Novel risk stratification for metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer.
    Gastrointest Endosc. 2017 Jul 13. pii: S0016-5107(17)32085.
    PubMed     Text format     Abstract available


    Gut

  5. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available


    Int J Cancer

  6. ROTA M, Pelucchi C, Bertuccio P, Matsuo K, et al
    Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium.
    Int J Cancer. 2017 Jul 18. doi: 10.1002/ijc.30891.
    PubMed     Text format     Abstract available

  7. LIU X, Zhang X, Zhang Z, Chang J, et al
    Plasma MicroRNA-based Signatures to Predict 3-year Postoperative Recurrence Risk for Stage II and III Gastric Cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30895.
    PubMed     Text format     Abstract available


    Int J Oncol

  8. XU M, Qin S, Cao F, Ding S, et al
    MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Int J Oncol. 2017 Jul 12. doi: 10.3892/ijo.2017.4072.
    PubMed     Text format     Abstract available

  9. LEE H, Saini N, Parris AB, Zhao M, et al
    Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Int J Oncol. 2017 Jul 13. doi: 10.3892/ijo.2017.4073.
    PubMed     Text format     Abstract available

  10. WANG R, Song Y, Liu X, Wang Q, et al
    UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Int J Oncol. 2017;50:1116-1126.
    PubMed     Text format     Abstract available


    Oncol Rep

  11. GONG YC, Ren GL, Liu B, Li F, et al
    miR206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5794.
    PubMed     Text format     Abstract available


    PLoS One

  12. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
    Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
    PLoS One. 2016;11:e0155669.
    PubMed     Text format     Abstract available


    Surgery

  13. KECK KJ, Maxwell JE, Menda Y, Bellizzi A, et al
    Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
    Surgery. 2017;161:272-279.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: